Hikma Pharm (HKMPY) 72.7000 $HKMPY
Hikma to Launch Colchicine 0.6mg Capsules
PR Newswire - Fri Jan 09, 5:10PM CST
Hikma Pharmaceuticals PLC ("Hikma"

(LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. ("Takeda"

has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the prophylaxis of gout flares in adults. The injunction, which was granted to Takeda on 9 October 2014, has been vacated.
Portfolio Update: The Good, The Bad, The Ugly!
Nick Mackintosh - at Seeking Alpha - Wed Jan 07, 12:04AM CST
BTI: 111.13 (-1.46), CCL: 43.48 (-0.89), DX: 8.34 (+0.01), XL: 35.74 (-0.07), DEO: 113.89 (-1.40), RYAAY: 61.46 (-2.33), BHP: 51.19 (+2.38), SHPG: 239.82 (+6.11), BP: 41.93 (+0.59), AMZN: 381.83 (+4.66), WPPGY: 111.99 (-0.98), UL: 43.03 (-0.17), GSK: 47.94 (+1.99), AZN: 69.96 (+0.20), NGG: 68.59 (-0.46)